Sign in

CIK 0001816736

  • Large accelerated filer

Disc Medicine, Inc.

Sign in to watch
Ticker
IRON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
851612845
Phone
+1 617-674-9274
Business address
321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
Former names
Gemini Therapeutics, Inc. /DE, FS Development Corp.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Planned sale Director sold 1,957 shares at an average $36.08 ($70,608)
  7. 4 Planned sale Director sold 201 shares at an average $28.63 ($5,755)
  8. 4 Planned sale Director sold 2,560 shares at an average $31.80 ($81,407)
  9. 4 Exercise or conversion Chief Medical Officer acquired 21,870 shares (option exercise)
  10. 4 Open-market sale Director sold 26,157 shares at $73.50 ($1,922,540)
  11. 4 Grant or award Chief Financial Officer acquired 18,165 shares (grant or award)
  12. 4 Grant or award Chief Executive Officer acquired 66,365 shares (grant or award)
  13. 4 Grant or award General Counsel acquired 14,035 shares (grant or award)
  14. 4 Grant or award Chief Business Officer acquired 18,165 shares (grant or award)
  15. 4 Grant or award Chief Medical Officer acquired 18,535 shares (grant or award)
  16. 4 Grant or award Chief Commercial Officer acquired 36,666 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Grant or award Chief Financial Officer acquired 36,666 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market sale Director sold 102,500 shares at $67.65 ($6,934,125)

Page 7 of 15 · 283 filings